Latest News

Neuren Pharmaceuticals (ASX:NEU) is back in focus after the European Medicines Agency's CHMP issued a positive opinion on its Rett syndrome treatment Daybue, clearing the path toward potential approval and European launch. See our latest analysis for Neuren Pharmaceuticals. That CHMP opinion has coincided with a sharp shift in sentiment toward Neuren Pharmaceuticals. The 7 day share price return of 36.82% and 90 day share price return of 46.72% contrast with a year to date share price decline...

Healthpeak Properties (DOC) was recently added to both the Russell 2500 Index and the Russell 2500 Value Benchmark. This type of inclusion can influence trading activity as index-tracking investors adjust their portfolios. See our latest analysis for Healthpeak Properties. Healthpeak Properties' recent index additions come after a strong run in the share price, with a 30-day share price return of 13.89% and a 90-day share price return of 30.99%. However, the 5-year total shareholder return of...

Sirma Group Holding JSC’s move to become a Temenos (SWX:TEMN) Referral Partner, focusing on Bulgaria and Albania, puts fresh attention on how this banking software company is building its regional reach through alliances. See our latest analysis for Temenos. Temenos shares trade at CHF69.0 after a 1 day share price return of 4.39% and a 7 day share price return of 5.10%. However, the share price is down 15.34% year to date, while the 1 year total shareholder return of 21.87% points to a...

China’s new zero tariff window for African exports is reshaping how raw materials, manufacturing and trade finance flow between the two regions, and that can ripple straight through to listed stocks. With African copper, lithium and cobalt entering China on easier terms, certain companies tied into these supply chains could experience shifts in costs, volumes or bargaining power. This article outlines what this development might mean for investors and highlights 3 stocks that appear...

In July 2026, Fannie Mae and Freddie Mac released expanded historical loan-level datasets for FICO Score 10T, covering real-world mortgage performance from April 2013 through September 2025 and available directly from the GSEs. This move deepens the mortgage industry’s shift toward modernized, trended-data credit scoring and lets stakeholders rigorously compare FICO Score 10T to legacy models using the same GSE performance data. We’ll now examine how broader FICO Score 10T performance data...

The European Medicines Agency committee recently recommended revoking the EU marketing authorisation for TAVNEOS®, affecting Fresenius Medical Care's treatment portfolio for kidney patients across the region. This regulatory setback raises questions about how Fresenius Medical Care will adapt its European therapy offering while continuing to invest in digital kidney care initiatives. We’ll now examine how the potential loss of TAVNEOS® in the EU reshapes Fresenius Medical Care’s longer-term...

Tandem Diabetes Care recently expanded compatibility of its t:slim X2 insulin pump with Control-IQ+ technology to work with Abbott’s FreeStyle Libre 3 Plus CGM in five European countries, while a new competitor, Modular Medical, reported first patient use of its Pivot tubeless insulin patch pump. This combination of broader CGM integration and the entry of a tubeless rival founded by Tandem’s original pump inventor highlights both ecosystem expansion and rising competitive pressure in...

Recently, Citi upgraded Texas Capital Bancshares to Neutral and Phoenix Merchant Partners announced a relationship with Texas Capital Alternative Asset Management to launch Spurstone Credit, a perpetual-life, non-traded closed-end fund focused on senior secured lending to core middle-market businesses. This combination of a major rating upgrade and an expanded private credit platform underscores how Texas Capital is reshaping its investment banking and alternative asset capabilities. With...

In late June 2026, Kimberly-Clark and Suzano completed the formation of Arbex, a US$3.40 billion joint venture that now operates as an independent global tissue and hygiene business managing brands such as Kleenex, Scott, Cottonelle, Andrex, and Viva across more than 70 markets. Arbex’s launch, staffed with senior leaders drawn from both Kimberly-Clark and Suzano, underscores how deeply this transaction reshapes Kimberly-Clark’s portfolio, operations, and long-term business focus. Next,...

Twilio recently drew investor attention as analysts revised their expectations ahead of the company’s upcoming earnings report, highlighting potential improvements in earnings per share and revenue. This shift in analyst sentiment, without any major new corporate announcements, underlines how expectations alone can meaningfully influence Twilio’s investment story. Next, we’ll examine how growing analyst confidence around Twilio’s earnings prospects could shape the company’s broader...

Ivanhoe Mines recently reported ongoing operational progress across its African portfolio, including improving performance at the Kamoa-Kakula copper complex and record zinc output from the Kipushi mine, reinforcing its focus on copper and critical minerals. This combination of recovering production, stronger asset performance, and an emphasis on disciplined capital allocation has sharpened investor attention on Ivanhoe’s diversified multi-mine platform within the Canadian mining...

RLI Corp (RLI) is in focus after being dropped from several Russell growth benchmarks. This move can prompt passive index selling and short-term volatility as index tracking funds adjust their holdings. See our latest analysis for RLI. Despite being dropped from several Russell growth benchmarks, RLI’s recent share price momentum has been strong, with a 1 month share price return of 19.81% and a 7 day share price return of 10.79%. This contrasts with a 1 year total shareholder return that is...

Apollo Commercial Real Estate Finance (ARI) has been dropped from several major equity benchmarks, including the Russell 2000 Growth, S&P Composite 1500, and S&P 600 indices, prompting investors to reassess index driven demand for the stock. See our latest analysis for Apollo Commercial Real Estate Finance. Against the index removals backdrop, Apollo Commercial Real Estate Finance’s share price has eased in the short term, with a 1-day share price return of 1.31% down and a 30-day share price...

Marcus & Millichap recently appointed Andee Robb as head of Retail Leasing & Advisory Services and Thomas Gorman as senior managing director leading the national net lease division, expanding its senior leadership bench in key retail-focused business lines. These hires, including the new retail leasing and net lease leadership roles created this quarter, highlight a clear push to deepen capabilities for retail and single-tenant net lease clients. We’ll now examine how the build-out of Marcus...

In June 2026, Deloitte and Appian announced an expanded global alliance to deploy AI-powered workflow and case management solutions to modernize legacy systems in the UK policing sector. The collaboration highlights Appian’s push to embed AI into mission-critical public safety operations, even as questions about its growth efficiency and reinvestment capacity remain. We’ll now examine how the expanded Deloitte alliance and ongoing efficiency concerns may reshape Appian’s broader investment...

In recent weeks, CBRE Group announced the upcoming release of its second-quarter 2026 results, highlighted raised full-year core EPS guidance, and continued to attract positive analyst attention alongside new leadership hires such as Grant Keyes in its Charlotte investor leasing team. Together, these developments underscore improving earnings expectations and management confidence at CBRE while some market participants still debate the long-term impact of AI on commercial real estate...

In late June 2026, U.S. regulators denied Polestar, majority-owned by Geely, authorization to sell new models from the 2027 model year onward because of rules restricting Chinese-linked connected-vehicle technology, although existing models can still be sold and serviced. This ruling raises questions for U.S. customers and dealers about long-term brand presence, resale values, and the durability of Polestar’s service network in the country. Next, we’ll examine how the looming 2027 U.S. sales...

Cirrus Aircraft Limited recently opened a new multi-million-dollar Duluth Talent Center focused on public-facing community engagement, recruiting, technical and field service maintenance training, and broader workforce development, while also approving a final US$0.12 per share (HK$0.94) dividend and appointing KPMG as its new auditor at the June 26, 2026 AGM. This combination of a centralized talent hub and a confirmed cash dividend highlights how Cirrus is investing in both its people...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Shareholders in CMC Markets Plc ( LON:CMCX ) may be thrilled to learn that the analysts have just delivered a major...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see ANY...

Despite posting healthy earnings, Oxford Instruments plc's ( LON:OXIG ) stock has been quite weak. Along with the solid...

Analyst estimates suggest these rare earth stocks may deliver a significant earnings uplift over the next several years.

Hims & Hers Health (HIMS) is back in focus after securing a $400 million financing arrangement with JPMorgan Chase Bank. This move improves liquidity while regulatory scrutiny of its peptide ambitions intensifies. See our latest analysis for Hims & Hers Health. At a share price of $37.57, Hims & Hers Health has seen strong short term momentum, with a 1 month share price return of 35.34% and 90 day share price return of 96.29%, while the 1 year total shareholder return declined 20.84% but the...